 Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial. The post NRXP Stock: The Cykotine Storm Drug News Sending NRx Pharma Shares Soaring appeared first on InvestorPlace. 